ppat.1009352.s006.tif (383.9 kB)
Binding activity of anti-SARS-CoV-2 RBD antibodies to MDCK-RBD cells measured by flow cytometry.
figure
posted on 2021-02-26, 18:43 authored by Kuan-Ying A. Huang, Tiong Kit Tan, Ting-Hua Chen, Chung-Guei Huang, Ruth Harvey, Saira Hussain, Cheng-Pin Chen, Adam Harding, Javier Gilbert-Jaramillo, Xu Liu, Michael Knight, Lisa Schimanski, Shin-Ru Shih, Yi-Chun Lin, Chien-Yu Cheng, Shu-Hsing Cheng, Yhu-Chering Huang, Tzou-Yien Lin, Jia-Tsrong Jan, Che Ma, William James, Rodney S. Daniels, John W. McCauley, Pramila Rijal, Alain R. TownsendAnti-influenza H3 MAb BS-1A was included as a control. Binding percentages are presented as mean ± standard error of the mean. Each experiment was repeated twice (n = 2). The 50% binding concentration (BC50) was measured with a curve fit using non-linear regression.
(TIF)
History
Usage metrics
Categories
Keywords
3 weeksantibody responseSARS-CoV -2 infectionACE 2-blocking responsePotent humoral responsesCOVID -19 patientscross-inhibiting clustersneutralising antibodiesplasmablast-derived IgGAnti-RBD MAbsplasmablast responses32 anti-spike MAbsvirus spike glycoproteinACE 2non-competing pairsplasmablast responsememory B cellsanti-non-RBD S 1plasmablast-derived MAbsanti-receptor-binding domainACE 2-blocking anti-RBD antibodies
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC